---
document_datetime: 2024-08-16 15:13:31
document_pages: 19
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/temozolomide-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: temozolomide-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 10.8125865
conversion_datetime: 2025-12-15 00:44:26.836122
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Temozolomide Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                       | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IA/0067              | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 16/08/2024                          | n/a                                         |                                  |           |
| N/0066               | Minor change in labelling or package leaflet not                                                                                                                                            | 14/08/2024                          |                                             | PL                               |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |             |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| IA/0065   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 12/01/2024 | n/a        |             |
| IA/0064   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 17/11/2023 | n/a        |             |
| IB/0063/G | This was an application for a group of variations. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 26/06/2023 | 05/07/2024 | SmPC and PL |

<div style=\"page-break-after: always\"></div>

| IA/0062/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                      | 31/01/2023   | n/a        |             |                                |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|--------------------------------|
|             | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change process | 24/03/2022   | n/a        |             | IA/0061/G in the manufacturing |
| IB/0060     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                            | 18/03/2022   | 06/03/2023 | SmPC and PL |                                |
| IAIN/0059   | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a new manufacturer (replacement or addition)                                                                                                     | 14/12/2021   | n/a        |             |                                |

<div style=\"page-break-after: always\"></div>

| IA/0058/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 13/12/2021   | 04/02/2022   | Annex II and PL   |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------------|
| IA/0057/G   | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of | 23/07/2021   | n/a          |                   |

<div style=\"page-break-after: always\"></div>

|           | - Administrative change - Deletion of sites - Administrative change - Deletion of sites - Administrative change - Deletion of sites                                                                                                                                                                                                                                                                  |            |            |                 | manufacturing sites A.7 manufacturing A.7 manufacturing A.7 manufacturing   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------------------------------------------------|
| IB/0056   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                       | 07/07/2021 | 04/02/2022 | SmPC and PL     |                                                                             |
| IAIN/0055 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                               | 27/01/2021 | 04/02/2022 | Annex II and PL |                                                                             |
| IB/0054/G | application for a group of variations. B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms B.II.e.1.z - Change in immediate packaging of the - Other variation | 23/09/2020 | n/a        |                 | This was an finished product                                                |
| IAIN/0053 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                   | 28/08/2020 | n/a        |                 |                                                                             |

<div style=\"page-break-after: always\"></div>

|             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by   | 15/06/2020   | 19/10/2020   | SmPC and PL   | IB/0052 the MAH   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|---------------|-------------------|
| IAIN/0051   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                     | 17/04/2020   | n/a          |               |                   |
| IA/0050     | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                             | 26/02/2020   | n/a          |               |                   |
| IAIN/0049   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                     | 27/01/2020   | n/a          |               |                   |
| IAIN/0048   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                         | 20/09/2019   | 19/10/2020   | SmPC          |                   |
| IA/0047     | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                            | 01/07/2019   | n/a          |               |                   |
| IAIN/0046/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                       | 05/03/2019   | n/a          |               |                   |

<div style=\"page-break-after: always\"></div>

|           | site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                      |            |            |                        |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| T/0045    | Transfer of Marketing Authorisation                                                                                                                                                                                                                          | 01/02/2019 | 25/02/2019 | SmPC, Labelling and PL |
| IAIN/0044 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                       | 27/09/2018 | 25/02/2019 | Annex II and PL        |
| IB/0043   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 23/05/2018 | 29/06/2018 | SmPC, Labelling and PL |
| IAIN/0042 | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                      | 22/01/2018 | n/a        |                        |
| IB/0041   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                               | 18/07/2017 | 29/06/2018 | SmPC and PL            |
| IAIN/0040 | B.III.2.a.1 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply                                                                                                                                                         | 18/01/2017 | n/a        |                        |

<div style=\"page-break-after: always\"></div>

|           | with the Ph. Eur. or with a national pharmacopoeia of a Member State - AS                                                                                                                                                                                                                                                                     |            |            |             |                           |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------------------------|
| IAIN/0039 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                            | 19/12/2016 | n/a        |             |                           |
| IA/0038   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                              | 29/09/2016 | n/a        |             |                           |
|           | This was an application for a group of variations. B.II.a.3.b.1 - Changes in the composition (excipients) of the finished product - Other excipients - Any minor adjustment of the quantitative composition of the finished product with respect to excipients B.II.a.3.z - Changes in the composition (excipients) product - Other variation | 27/06/2016 | 22/05/2017 | SmPC and PL | IB/0037/G of the finished |
| IA/0036   | B.II.b.4.b - Change in the batch size (including batch size ranges) of the finished product - Downscaling down to 10-fold                                                                                                                                                                                                                     | 17/02/2016 | n/a        |             |                           |
| II/0035   | B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range                                                                                                                                                                                           | 22/10/2015 | n/a        |             |                           |
| IB/0033   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following                                                                                                                                                                                                                                                | 14/07/2015 | 02/06/2016 | SmPC and PL |                           |

<div style=\"page-break-after: always\"></div>

|           | of the same change for the reference - Implementation of change(s) for which NO additional data is required to be submitted by MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |            |                        | assessment product new the   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------|
| IAIN/0034 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 26/06/2015 | 02/06/2016 | Annex II and PL        |                              |
| IB/0031/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.e.1.b.1 - Change in immediate packaging of the finished product - Change in type/addition of a new container - Solid, semi-solid and non-sterile liquid pharmaceutical forms B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes | 12/06/2015 | 02/06/2016 | SmPC, Labelling and PL |                              |

<div style=\"page-break-after: always\"></div>

| B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.) the range of the currently B.II.e.5.a.1 - Change product - Change in tablets, ampoules, etc.)   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|             | B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes                                                                                                                                     |            |     |            |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------|
| IAIN/0032/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products | 05/06/2015 | n/a | B.II.e.7.b |

<div style=\"page-break-after: always\"></div>

|             | components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State   |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                             |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| T/0029      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                   | 10/04/2015 | 27/05/2015 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                             |
| IAIN/0030/G | This was an application for a group of variations. A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location    | 18/03/2015 | 27/05/2015 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                             |
| R/0026      | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                               | 23/10/2014 | 12/01/2015 | SmPC, Annex II, Labelling and PL | Based on the review of the available information, the CHMP is of the opinion that the quality, the safety and the efficacy of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considers the benefit/risk profile of Temozolomide Hospira continues to be favourable. The CHMP is also of the opinion that the renewal can be granted with unlimited validity. |
| IG/0477     | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the                                                                                                                                                                     | 03/09/2014 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

|           | PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |            |            |             |         |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------|
| IB/0027   | Update of section 4.8 of the SmPC to include the calculated frequency of hepatic-related disorders following adoption of the same changes for the reference product. Section 4 of the Package Leaflet was updated accordingly. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by | 14/08/2014 | 12/01/2015 | SmPC and PL | the MAH |
| IB/0025   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                        | 12/02/2014 | 28/02/2014 | SmPC and PL |         |
| IA/0024/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                            | 17/12/2013 | n/a        |             |         |

<div style=\"page-break-after: always\"></div>

|           | importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place   |            |     | B.II.b.2.a - Change to   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------------|
| IA/0022/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place A.7 - Administrative change - Deletion of sites                                                    | 11/12/2013 | n/a | manufacturing            |
| IG/0382   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                  | 02/12/2013 | n/a |                          |
| IA/0021   | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                       | 14/08/2013 | n/a |                          |
| IG/0317   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                   | 23/07/2013 | n/a |                          |
| IAIN/0019 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                                                                                                    | 03/06/2013 | n/a |                          |

<div style=\"page-break-after: always\"></div>

|         | site                                                                                                                                                                                                                                                                                                                                                                                       |            |            |                                  |             |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------|
| IG/0286 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                             | 12/04/2013 | n/a        |                                  |             |
| IB/0016 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                                                             | 04/04/2013 | 28/02/2014 | SmPC and PL                      |             |
| IA/0017 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                               | 20/03/2013 | n/a        |                                  |             |
| IA/0015 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                               | 20/12/2012 | n/a        |                                  |             |
| IB/0014 | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                  | 21/11/2012 | 28/02/2014 | SmPC                             |             |
| IB/0013 | In line with the CHMP adoption of variations to the Marketing Authorisation of the Originator Product Temodal (EMEA/H/C222/II/59) on 24.05.2012 the Product Information (PI) for Temozolomide Hospira was updated with changes to the SmPC in order to add a warning regarding the risk of myelosuppression including prolonged pancytopenia following the assessment of PSUR. The package | 09/10/2012 | 25/10/2012 | SmPC, Annex II, Labelling and PL | leaflet was |

<div style=\"page-break-after: always\"></div>

|             | In addition, the Spanish PI translation was brought in line with the approved Spanish text of the originator product. Furthermore, the PI is brought in line with the latest QRD template, version 8. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH   |            |            |      |                |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|----------------|
| N/0012      | To combine the package leaflets as did the reference product and to add the list of the local representatives in annex IIIB. Minor change in labelling or package leaflet not the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                         | 13/08/2012 | 25/10/2012 | PL   | connected with |
| IB/0010     | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                              | 22/06/2012 | 25/10/2012 | SmPC |                |
| IAIN/0011   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                     | 12/06/2012 | n/a        |      |                |
| IAIN/0009/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance                                                                                                                                                                                                                                                                                                                                                  | 20/04/2012 | n/a        |      |                |

<div style=\"page-break-after: always\"></div>

|         | system as described in the DDPS - Change in the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.g - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the site undertaking pharmacovigilance activities C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system   |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                                |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0008 | B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                     | 10/01/2012 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                |
| IB/0006 | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                         | 22/11/2011 | 25/05/2012 | SmPC                   |                                                                                                                                                                                                                                                                                                                                                                                                                |
| IB/0007 | to update section 4.8 of the SmPC for Temozolomide Hospira Hard Capsules to include information on the possible risk of hepatotoxicity associated with Temozolomidel identified following a cumulative review. The PL has been updated accordingly. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                              | 21/10/2011 | n/a        | SmPC, Labelling and PL | to update section 4.8 of the SmPC to include information on the possible risk of hepatotoxicity associated with Temozolomidel identified following a cumulative review. The PL has been updated accordingly. Furthermore, additional editorial changes have been made to bring the SmPC and PL in line with the innovator. Additionally, typographical errors in DA, SV, HU, PT and FI annexes were corrected. |

<div style=\"page-break-after: always\"></div>

| IB/0005/G   | This was an application for a group of variations. B.I.d.1.z - Stability of AS - Change in the re-test period/storage period or storage conditions - Other variation B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.d.1.a.1 - Stability of AS - Change in the re-test   | 08/09/2011   | n/a        |                           |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|---------------------------|
| II/0004     | To increase the shelf-life specification limit in the finished product for Impurity A and for the Total Impurities. B.II.d.1.f - Change in the specification parameters and/or limits of the finished product - Deletion of a specification parameter which may have a significant effect on the overall quality of the finished product                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 21/07/2011   | 21/07/2011 |                           |
| II/0001/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 14/04/2011   | 27/05/2011 | SmPC, Annex II, Labelling |

<div style=\"page-break-after: always\"></div>

|         | To reduce the amount of desiccant and to replace the desiccant disc with a 0.25 g desiccant pouch. To restrict the special storage condition to \"Do not store above 25C\". To reduce the shelf-life from 2 years to 1 year for all capsules strengths To change the medicinal product's release and shelf- life specification To delete all HDPE bottle presentations This variation is linked to the quality defect with broken capsules and therefore submitted as a Type II variation. The MAH has identified the desiccant to be the root cause. In addition, the MAH has taken the opportunity to delete the version number of the DDPS in Annex II. B.II.e.1.b.2 - Change in immediate packaging of the finished product - Type of container - Sterile medicinal products and biological/immunological medicinal products B.II.e.5.b - Change in pack size of the finished   |            |     |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0003 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 01/12/2010 | n/a |
| IA/0002 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 03/11/2010 | n/a |